Skip to main content
Log in

Giant axonal neuropathy (GAN): an immunohistochemical and ultrastructural study report of a Latin American case

  • Case Reports
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Summary

Giant axonal neuropathy (GAN), a progressive childhood disorder of intermediate filaments (IF), is characterized by a peripheral neuropathy and central nervous system involvement. Twenty-eight cases have been reported while several pathogenic hypotheses have been proposed. Sural nerve biopsy of a 10-year-old Argentinian girl showed a reduced number of myelinated fibers as well as several enlarged axons up to 30 μm in diameter, thinly myelinated or devoid of myelin sheath, displaying accumulation of neurofilaments (NF), but few microtubules (MT) beneath the axolemmal membrane. There was IF accumulation in Schwann and perineural cells as well as in melanocytes, fibroblasts, pericytes, endothelial and epithelial cells in both nerve and skin biopsy. Our findings strongly support GAN as a generalized IF disorder with MT segregation from NF in giant axons. Abnormal NF phosphorylation is suggested by heavy immunostaining of enlarged axons by a monoclonal antibody to NF phosphorylated determinants (SMI 31-Sternberger's) and lack of reaction with a monoclonal antibody with different phosphoepitopes affinity (SMI 34-Sternberger's).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bancher C, Lassmann H, Budka H, Jellinger K, Grundke-Iqbal I, Iqbal K, Wiche G, Seitelberger F, Wisniewski H (1989) An antigenic profile of Lewy bodies: immunocytochemical indication for protein phosphorylation and ubiquitination. J Neuropathol Exp Neurol 48:81–93

    Google Scholar 

  2. Berg BO, Rosenberg SH, Asbury AK (1972) Giant axonal neuropathy. Pediatrics 49:894–899

    Google Scholar 

  3. Boltshauser E, Bischoff A, Isler W (1977) Giant axonal neuropathy: report of a case with normal hair. J Neurol Sci 31:269–278

    Google Scholar 

  4. Buissonniere RF, Routon MC, Robian O, Ponsot G, Arthuis M (1989) Giant axon neuropathy: intermediary filaments disease with peripheral and central nervous system lesions. Rev Neurol (Paris) 145:355–362

    Google Scholar 

  5. Carpenter S, Karpati G, Andermann F, Gold R (1974) Giant axonal neuropathy: a clinically and morphologically distinct neurological disease. Arch Neurol 31:312–316

    Google Scholar 

  6. Donaghy M, Brett EM, Cormerod IE, King R, Thomas P (1988) Giant axonal neuropathy observations on a further patient. J Neurol Neurosurg Psychiatry 51:991–994

    Google Scholar 

  7. Donaghy M, King R, Thomas PK, Workman J (1988) Abnormalities of the axonal cytoskeleton in giant axonal neuropathy. J Neurocytol 17:197–208

    Google Scholar 

  8. Dooley JM, Oshima Y, Becker LE, Murphy EG (1981) Clinical progression of giant axonal neuropathy over a twelve-year period. Can J Neurol Sci 8:321–323

    Google Scholar 

  9. Fois A, Balestri P, Farnetani MA, Berardi R, Mattei R, Laurenzi E, Alessandrini C, Gerli R, Ribuffo A, Calvieri S (1985) Giant axonal neuropathy. Endocrinological and histological studies. Eur J Pediatr 144:274–280

    Google Scholar 

  10. Gambarelli D, Hassoun J, Pellissier JF, Livet MO, Pinsard N, Toga M (1977) Giant axonal neuropathy: involvement of peripheral nerve, myenteric plexus and extra-neuronal area. Acta Neuropathol (Berl) 39:261–269

    Google Scholar 

  11. Goldman JE, Corbin E (1988) Isolation of a major protein component of Rosenthal fibers. Am J Pathol 30:569–577

    Google Scholar 

  12. Hudson A, Ballinger WE (1984) Infantile giant axonal neuropathy (abstract). Ann Neurol 16:407

    Google Scholar 

  13. Igisu H, Ohta M, Tabira T, Hosokawa S, Goto I, Kuroiwa Y (1975) Giant axonal neuropathy: a clinical entity affecting the central as well as the peripheral nervous system. Neurology 25:717–721

    Google Scholar 

  14. Ionasescu B, Searby CH, Rubenstein P, Sandra A, Cancilla P, Robillard J (1983) Giant axonal neuropathy: normal protein composition of neurofilaments. J Neurol Neurosurg Psychiatry 46:551–554

    Google Scholar 

  15. Jedrzejowska H, Drac H (1977) Infantile chronic peripheral neuropathy with giant axons: report of a case. Acta Neuropathol (Berl) 37:213–217

    Google Scholar 

  16. Jones MZ, Nigro MA, Barre PS (1979) Familial “giant axonal neuropathy” (abstract). J Neuropathol Exp Neurol 38:324

    Google Scholar 

  17. Kinney RB, Gottfried MR, Hodson AK, Autilio-Gambetti L, Graham DG (1985) Congenital giant axonal neuropathy. Arch Pathol Lab Med 109:639–641

    Google Scholar 

  18. Klymkowsky MW, Plummer DJ (1985) Giant axonal neuropathy: a conditional mutation affecting cytoskeletal organization. J Cell Biol 100:245–250

    Google Scholar 

  19. Koch T, Schultz P, Williams R, Lampert P (1977) Giant axonal neuropathy: a childhood disorder of microfilaments. Ann Neurol 1:438–451

    Google Scholar 

  20. Kretzchmar HA, Berg BO, Davis RL (1987) Giant axonal neuropathy: a neuropathological study. Acta Neuropathol (Berl) 73:138–144

    Google Scholar 

  21. Larbrisseau A, Jasmin G, Hausser C, Brochu P, Geoffroy G (1979) Generalized giant axonal neuropathy — a case with features of Fazio-Londe disease. Neuropaediatrie 10:76–86

    Google Scholar 

  22. Leigh PN, Dodson A, Swash M, Brion JP, Anderton BH (1989) Cytoskeletal abnormalities in motor neuron disease. Brain 112:521–535

    Google Scholar 

  23. Maia M, Pires MM, Guimaraes A (1988) Giant axonal disease: report of three cases and review of the literature. Neuropediatrics 19:10–15

    Google Scholar 

  24. Manetto V, Fadi W, Karim A, Perry G, Tabaton M, Autilio-Gambetti L, Gambetti P (1989) Selective presence of ubiquitin in intracellular inclusions. Am J Pathol 134:505–513

    Google Scholar 

  25. Matus A (1988) Neurofilament protein phosphorylation —where, when and why. Trend Neurosci 11:291–292

    Google Scholar 

  26. Mayor DH, Hampton JC, Rosario B (1964) A simple method for removing the resin from eposi-embedded tissue. J Biophys Biochem Cytol 9:909–910

    Google Scholar 

  27. Mizuno Y, Otsuka S, Takano Y, Suzuki Y, Hosaka A, Kaga M, Segawa M (1979) Giant axonal neuropathy: combined central and peripheral nervous system disease. Arch Neurol 36:107–108

    Google Scholar 

  28. Ouvrier RA, Prineas J, Walsh JC, Reye RDK, McLeod JG (1974) Giant axonal neuropathy: a thrid case. Proc Aust Assoc Neurol 11:137–144

    Google Scholar 

  29. Papasozomenos S, Binder L, Bender P, Payne M (1985) Microtubule-associated Protein 2 within axons of spinal motor neurons: associations with microtubules and neurofilaments in normal an b, b′-iminodipropionitrile-treated axons. J Cell Biol 100:74–85

    Google Scholar 

  30. Peiffer J, Schlote W, Bischoff A, Boltshauser F, Muller G (1977) Generalized Giant Axonal Neuropathy. Acta Neuropathol (Berl) 40:213–218

    Google Scholar 

  31. Pena SDJ (1983) Immunocytochemical studies of intermediate filaments aggregates and their relationship to microtubules in cultured skin fibroblasts from patients with giant axonal neuropathy. Eur J Cell Biol 31:227–334

    Google Scholar 

  32. Prineas J (1969) The pathogenesis of dying-back polyneuropathies. II. An ultrastructural study of experimental acrylamide intoxication in the cat. J Neuropathol Exp Neurol 28:598–691

    Google Scholar 

  33. Rizzuto N, Terzian H, Galiazzo-Rizzuto S (1977) Toxic polyneuropathy in Italy due to leather cement poisoning in shoe industries. A light and electron microscopic study. J Neurol Sci 31:343–354

    Google Scholar 

  34. Schaumburg HH, Wisniewski HM, Spencer PS (1974) Ultrstructural studies of the dying-back process. I. Peripheral nerve terminal and axon degeneration in systemic acrylamide intoxication. J Neuropathol Exp Neurol 33:260–284

    Google Scholar 

  35. Schlaepfer W (1987) Neurofilaments: structure, metabolism and implication in disease. J Neuropathol Exp Neurol 46:117–129

    Google Scholar 

  36. Sternberger L (1987) Immunocytochemistry, 3rd edn. Wiley, New York, pp 461–464

    Google Scholar 

  37. Sternberger L, Guth L, Barret CH, Donati E, Andrews N, Rawser M, Sternberger N (1987) Neurofilaments phosphorylation in spinal cord injury. J Neuropathol Exp Neurol 46:350 (abstr)

    Google Scholar 

  38. Takebe T, Koide N, Takahashi G (1981) Giant axonal neuropathy: report of histological studies. Neuropediatrics 12:392–404

    Google Scholar 

  39. Tandan R, Little BW, Emery ES, Good PS, Pendlebury WW, and Bradley G (1987) Childhood giant axonal neuropathy. Case report and review of the literature. J Neurol Sci 96:205–228

    Google Scholar 

  40. Thomas C, Love MB, Powell HC, Schultz P, Lampert PW (1987) Giant axonal neuropathy: correlation of clinical findings with postmortem neuropathology. Ann Neurol 22:79–84

    Google Scholar 

  41. Toru-Delbauffe D, Pierre M, Osty J, Chantoux F, Francon J (1986) Properties of neurofilament protein kinase. Biochem J 235:283–289

    Google Scholar 

  42. Watters G, Karpati G, Carpenter S, Humphreys P, Anderman F (1978) Giant axonal neuropathy (GAN): a disorder of the central and peripheral nervous system: clinical, neurophysiological and ultrastructural findings in two patients and review of five previous cases. Can J Neurol Sci 5:340–341

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taratuto, A.L., Sevlever, G., Saccoliti, M. et al. Giant axonal neuropathy (GAN): an immunohistochemical and ultrastructural study report of a Latin American case. Acta Neuropathol 80, 680–683 (1990). https://doi.org/10.1007/BF00307639

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00307639

Key words

Navigation